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Haematohidrosis treated with 
propranolol: a case report
A 15-year-old girl was referred to our hospital in 2015 with a 
3-month history of spontaneous mucocutaneous bleeding. Her 
clinical history showed she had suffered from a major stressful 
event (Abruzzo earthquake in 2006).
Initially the bleeding was sporadic, clear and localised to the 
eyelids, but after a few weeks became darker, more frequent and 
widespread (figure 1). Before and after the episodes, no signs of 
wounds or scrapes were observed. The episodes were usually 
asymptomatic. Sometimes headaches and asthaenia preceded the 
bleeding.
Diagnosis of haematidrosis was clinically established and a 
treatment with a non-selective β-blocker (propranolol) at a dose 
of 10 mg, every 12 hours, was started. Although the number of 
episodes reduced, 1–2 hours before the propranolol administra-
tion, some bleeding was still observed. Therefore the patient was 
treated with propranolol every 8 hours, and a complete disease 
resolution was observed during the follow-up.
Haematidrosis is a very rare disease characterised by recur-
rent spontaneous episodes of blood sweating from intact skin.1 
Considering the possible role of sympathetic nervous system 
on this condition, some authors proposed a treatment with 
propranolol.2 3
In conclusion, even if a sporadic self-limited resolution of some 
cases is described, our report suggests the efficacy of propranolol 
in treating patients with haematidrosis.
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Figure 1 The patient during a bleeding episode.
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